← Leaderboards
Eric Carter Bartee
University Of New Mexico Health Scis Ctr
$4,469,205
Attributed
$4,469,205
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.4K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,469,205 · 6
By mechanism
R01$2,996,804 · 2
R21$1,210,545 · 3
K22$261,856 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMediatingVirusCellsMyxoma VirusViralDesignOncolyticPreventMolecularOncolytic VirusesSolid NeoplasmIn VitroBaseOryctolagus CuniculusPathway InteractionsMyxomaSuccessTranslationsBindingDefectPublic HealthProteinsPlay
Grant awards (16)
Impact of TNF on Oncolytic Virotherapy$438,164
R01 · FY2025 · CA · contact PI
Impact of TNF on Oncolytic Virotherapy$416,256
R01 · FY2024 · CA · contact PI
Impact of TNF on Oncolytic Virotherapy$438,164
R01 · FY2023 · CA · contact PI
Impact of extracellular potassium on oncolytic therapy$208,229
R21 · FY2023 · CA · contact PI
Impact of extracellular potassium on oncolytic therapy$177,066
R21 · FY2022 · CA · contact PI
Treatment of multiple myeloma using oncolytic myxoma virus$346,556
R01 · FY2020 · CA · contact PI
Rationally combining oncolytic virotherapy and TIM3 blockade$227,250
R21 · FY2020 · AI · contact PI
Treatment of multiple myeloma using oncolytic myxoma virus$331,721
R01 · FY2019 · CA · contact PI
Rationally combining oncolytic virotherapy and TIM3 blockade$186,875
R21 · FY2019 · AI · contact PI
Treatment of multiple myeloma using oncolytic myxoma virus$341,981
R01 · FY2018 · CA · contact PI
Treatment of multiple myeloma using oncolytic myxoma virus$341,981
R01 · FY2017 · CA · contact PI
Impact of envelope proteins on poxviral pathogenesis$224,250
R21 · FY2017 · AI · contact PI
Treatment of multiple myeloma using oncolytic myxoma virus$341,981
R01 · FY2016 · CA · contact PI
Impact of envelope proteins on poxviral pathogenesis$186,875
R21 · FY2016 · AI · contact PI
Treatment of transplanted and established multiple myeloma using oncolytic myxoma$108,000
K22 · FY2014 · AI · contact PI
Treatment of transplanted and established multiple myeloma using oncolytic myxoma$153,856
K22 · FY2013 · AI · contact PI